6.30

2.48% -0.16

Pulmonx Corp (LUNG)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$6.46

Offen:

$6.48

24-Stunden-Volumen:

168.37K

Relative Volume:

0.73

Marktkapitalisierung:

$255.09M

Einnahmen:

$68.68M

Nettoeinkommen (Verlust:

$-60.84M

KGV:

-3.913

EPS:

-1.61

Netto-Cashflow:

$-38.42M

1W Leistung:

+1.61%

1M Leistung:

+4.48%

6M Leistung:

-21.93%

1J Leistung:

-43.19%

1-Tages-Spanne:

$6.26

$6.66

1-Wochen-Bereich:

$6.12

$7.09

52-Wochen-Spanne:

$5.46

$14.84

Pulmonx Corp Stock (LUNG) Company Profile

Firmenname

Pulmonx Corp

Sektor

Healthcare (1200)

Branche

Medical Devices (153)

Telefon

650-364-0400

Adresse

700 CHESAPEAKE DRIVE, REDWOOD CITY

Mitarbeiter

279

Twitter

Nächster Verdiensttermin

2024-10-30

Neueste SEC-Einreichungen

LUNG's Discussions on Twitter

Vergleichen Sie LUNG mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
LUNG Pulmonx Corp	6.30	255.09M	68.68M	-60.84M	-38.42M	-1.61
ABT Abbott Laboratories	118.95	208.18B	41.22B	5.77B	6.49B	2.94
SYK Stryker Corp	388.14	148.70B	21.97B	3.59B	3.21B	6.74
BSX Boston Scientific Corp	90.75	133.32B	15.91B	1.79B	1.89B	0.82
MDT Medtronic Plc	86.27	111.27B	33.00B	4.29B	5.50B	2.71
EW Edwards Lifesciences Corp	72.07	42.66B	6.60B	4.16B	490.10M	2.34

Pulmonx Corp Stock (LUNG) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-06-04	Eingeleitet	Lake Street	Buy
2024-02-23	Herabstufung	Wells Fargo	Overweight → Equal Weight
2023-09-05	Eingeleitet	Craig Hallum	Buy
2023-02-27	Hochstufung	Wells Fargo	Equal Weight → Overweight
2023-01-03	Herabstufung	BofA Securities	Neutral → Underperform
2022-12-12	Hochstufung	Citigroup	Neutral → Buy
2022-07-11	Herabstufung	Citigroup	Buy → Neutral
2022-03-02	Fortgesetzt	BofA Securities	Neutral
2021-12-08	Hochstufung	Piper Sandler	Neutral → Overweight
2021-04-01	Eingeleitet	Citigroup	Buy
2021-03-25	Eingeleitet	Piper Sandler	Neutral
2021-03-10	Hochstufung	BofA Securities	Neutral → Buy
2021-01-04	Herabstufung	BofA Securities	Buy → Neutral
2020-10-26	Eingeleitet	BofA Securities	Buy
2020-10-26	Eingeleitet	Canaccord Genuity	Buy
2020-10-26	Eingeleitet	Morgan Stanley	Equal-Weight
2020-10-26	Eingeleitet	Stifel	Buy
2020-10-26	Eingeleitet	Wells Fargo	Equal Weight

Alle ansehen

Pulmonx Corp Aktie (LUNG) Neueste Nachrichten

Nov 27, 2024

Pulmonx (NASDAQ:LUNG) vs. Fractyl Health (NASDAQ:GUTS) Head-To-Head Review - Defense World

Nov 27, 2024

Nov 26, 2024

Pulmonx director French sells $132,600 in stock - Investing.com

Nov 26, 2024

Millrace Asset Group Inc. Purchases Shares of 167,725 Pulmonx Co. (NASDAQ:LUNG) - MarketBeat

Nov 26, 2024

Nov 21, 2024

Does Pulmonx (LUNG) Have the Potential to Rally 117.74% as Wall Street Analysts Expect? - Yahoo Finance

Nov 21, 2024

Nov 20, 2024

Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference - Yahoo Finance

Nov 20, 2024

Nov 19, 2024

Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers - Yahoo Finance

Nov 19, 2024

Nov 13, 2024

Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - Yahoo Finance

Nov 07, 2024

Nov 05, 2024

Wall Street Analysts Predict an 89.61% Upside in Pulmonx (LUNG): Here's What You Should Know - Yahoo Finance

Nov 05, 2024

Nov 02, 2024

Here's What Analysts Are Forecasting For Pulmonx Corporation (NASDAQ:LUNG) After Its Third-Quarter Results - Yahoo Finance UK

Nov 02, 2024

Nov 01, 2024

Pulmonx Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Nov 01, 2024

Pulmonx Corporation (NASDAQ:LUNG) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 01, 2024

Oct 31, 2024